Enlivex因股价低于1美元收到纳斯达克不合规通知

2026-05-16 04:16

Enlivex(ENLV) was notified by Nasdaq that its share price stayed below the $1 minimum bid requirement for 30 consecutive business days.
The company has until November 9, 2026, to regain compliance.
If compliance is not restored by the deadline, Enlivex may qualify for an additional 180-day extension period. T
o secure the second compliance period, the company may need to implement a reverse stock split and meet other Nasdaq Capital Market listing standards.

More on Envilex Therapeutics